Subash Babu Selected Research

Extrapulmonary Tuberculosis

1/2020	Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
11/2019	Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children.
1/2019	Helminth mediated modulation of the systemic and mycobacterial antigen - stimulated cytokine profiles in extra-pulmonary tuberculosis.
5/2013	Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Subash Babu Research Topics

Disease

63	Infections 11/2021 - 03/2005
53	Tuberculosis (Tuberculoses) 11/2022 - 07/2009
37	Pulmonary Tuberculosis 01/2022 - 12/2012
26	Latent Tuberculosis 01/2022 - 07/2009
23	Inflammation (Inflammations) 01/2022 - 04/2011
18	Lymph Node Tuberculosis (Scrofula) 01/2022 - 01/2013
13	Coinfection 01/2021 - 07/2009
13	Filarial Elephantiasis (Lymphatic Filariasis) 12/2018 - 06/2005
12	COVID-19 01/2022 - 01/2021
11	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2012
8	Diabetes Mellitus 01/2022 - 10/2013
6	Lymphedema (Milroy Disease) 12/2014 - 03/2005
4	Extrapulmonary Tuberculosis 01/2020 - 05/2013
4	Insulin Resistance 03/2015 - 11/2013
3	Malnutrition (Nutritional Deficiencies) 11/2020 - 04/2016
3	Parasitic Diseases (Parasitic Disease) 01/2017 - 08/2007
2	Filariasis 01/2021 - 04/2006
2	Acute-Phase Reaction 01/2021 - 01/2017
2	Lymphadenitis (Adenitis) 11/2020 - 08/2020
2	Latent Infection 01/2019 - 11/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 03/2015 - 01/2014
2	Disease Progression 03/2015 - 07/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 05/2012
2	Asymptomatic Infections 01/2012 - 01/2012
1	Pregnancy Complications 12/2021
1	Virus Diseases (Viral Diseases) 09/2021
1	COVID-19 related pediatric multisystem inflammatory disease 04/2021

Drug/Important Bio-Agent (IBA)

82	CytokinesIBA 01/2022 - 06/2005
44	AntigensIBA 01/2022 - 01/2009
22	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2012
13	ChemokinesIBA 01/2022 - 10/2013
13	Interleukin-10 (Interleukin 10)IBA 04/2021 - 01/2012
12	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2021 - 01/2012
11	Matrix Metalloproteinases (MMPs)IBA 05/2021 - 01/2012
10	AnthelminticsIBA 01/2020 - 01/2012
9	Interleukin-2 (IL2)IBA 01/2022 - 04/2006
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2012
7	Interleukin-17 (Interleukin 17)IBA 12/2021 - 01/2009
7	Lipopolysaccharide ReceptorsIBA 11/2021 - 01/2014
7	C-Reactive ProteinIBA 07/2021 - 01/2013
6	AdipokinesIBA 01/2022 - 05/2012
6	LipopolysaccharidesIBA 07/2021 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 07/2012
5	Biological ProductsIBA 01/2020 - 10/2013
5	Interleukin-9 (Interleukin 9)IBA 01/2020 - 09/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2009
4	interleukin-21 (interleukin 21)IBA 01/2022 - 01/2009
4	Pharmaceutical PreparationsIBA 01/2022 - 07/2014
4	InterleukinsIBA 12/2021 - 07/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 01/2016
4	Metalloproteases (Metalloproteinases)IBA 05/2021 - 01/2012
4	Immunoglobulin G (IgG)IBA 01/2021 - 05/2017
4	Interleukin-4 (Interleukin 4)IBA 01/2020 - 09/2013
3	Interleukin-15 (Interleukin 15)IBA 01/2022 - 01/2017
3	Interleukin-7 (Interleukin 7)IBA 01/2022 - 01/2017
3	LigandsIBA 11/2021 - 04/2006
3	InterferonsIBA 09/2021 - 07/2009
3	VaccinesIBA 09/2021 - 07/2014
3	HaptoglobinsIBA 07/2021 - 01/2012
3	lipopolysaccharide-binding proteinIBA 07/2021 - 01/2012
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 07/2009
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 03/2015
3	Interleukin-12 (IL 12)IBA 01/2020 - 07/2009
3	Interleukin-18 (Interleukin 18)IBA 01/2019 - 01/2017
3	Messenger RNA (mRNA)IBA 11/2013 - 06/2005
2	MitogensIBA 01/2022 - 01/2017
2	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 07/2021 - 01/2020
2	Interleukin-33IBA 04/2021 - 01/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2021 - 03/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2021 - 04/2012
2	Immunoglobulin M (IgM)IBA 01/2021 - 05/2017
2	AntibodiesIBA 01/2021 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 12/2014
2	Peptides (Polypeptides)IBA 01/2020 - 01/2017
2	Antimicrobial PeptidesIBA 01/2020 - 01/2017
2	Interleukin-13IBA 01/2020 - 01/2014
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2020 - 01/2012
2	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 01/2018
2	EicosanoidsIBA 01/2019 - 07/2014
2	Tuberculin (PPD)IBA 11/2018 - 01/2010
2	interleukin 20 (IL-20)IBA 01/2018 - 12/2015
2	Interleukin-27 (Interleukin 27)IBA 11/2017 - 09/2015
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 01/2009
2	Heme Oxygenase-1IBA 09/2015 - 01/2013
2	Chaperonin 60IBA 04/2015 - 12/2011
2	EnzymesIBA 03/2015 - 01/2012
2	Interleukin-1 (Interleukin 1)IBA 07/2014 - 07/2014
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2012 - 07/2011
1	AngiopoietinsIBA 11/2021
1	S100A12 ProteinIBA 11/2021
1	Advanced Glycation End ProductsIBA 11/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2021
1	Granzymes (Granzyme)IBA 04/2021

Therapy/Procedure

15	Therapeutics 01/2020 - 01/2014
6	Drug Therapy (Chemotherapy) 01/2018 - 07/2009
3	Immunomodulation 01/2021 - 05/2012
3	Glycemic Control 01/2019 - 11/2013